Table 1.

Available seasonal influenza vaccines in the EU/EEA (2015–16 season).

Manufacturer	Name of product*	Vaccine type	Adjuvant	Administration route	Produced in	Age recommended
Mylan	Trivalent: Influvac Imuvac	Inactivated	None	Intramuscular	Egg	From 6 months
AstraZeneca	Quadrivalent: Fluenz tetra (Flumist quadrivalent)	Live attenuated	None	Intranasal	Egg	From 24 months to 17 years
GlaxoSmithKline	Trivalent: Fluarix** Alpharix Influsplit Quadrivalent: Fluarix Tetra Alpharix Tetra Influsplit Tetra	Inactivated/ split	None	Trivalent: Intramuscular or subcutaneous Quadrivalent: Intramuscular	Egg	Trivalent: From 6 months Quadrivalent: From 3 years
Seqirus	Trivalent: Agrippal Fluvirin Optaflu Fluad	Inactivated /subunit	None None None Squalene (MF59)	Intramuscular or subcutaneous Intramuscular	Egg Egg Cell Egg	From 6 months From 4 years From 18 years From 65 years
Omninvest	Trivalent: Fluval AB	Inactivated	Aluminium phosphate gel	Intramuscular	Cell	From 6 months
Pfizer/ CSL Australia	Trivalent: Afluria*** Enzira	Inactivated/Split	None	Intramuscular	Egg	From 5 years
Sanofi Pasteur	Trivalent: Vaxigrip** Intanza 9µg  Intanza 15µg	Inactivated Inactivated Inactivated	None None None	Intramuscular Intradermal Intradermal	Egg Egg Egg	From 6 months From 18-59 years From 60 yrs

^*The same product may be sold under different names

^**Split virion by Triton X-100 and formaldehyde inactivated

^***Beta-propriolactone-inactivated and taurodeoxycholate split virion vaccine.

Overview of available seasonal influenza vaccines in the EU/EEA (2015–16 season).⁸⁷ (modified)